NICE has assessed the MiniMed Paradigm Veo system and the Vibe and G4 PLATINUM CGM system for managing blood glucose levels in type 1 diabetes, to help the NHS decide whether to use them.
In these systems, a sensor is placed under the skin to constantly measure the glucose levels and an insulin pump delivers insulin continuously. The glucose level results help to monitor how much insulin is needed.
NICE has recommended the MiniMed Paradigm Veo system for people who have hypoglycaemic events often or without warning, which makes them anxious. A healthcare team experienced in using this system should supervise its use. The system should only be used if:
- The person or their carer:
- agrees to use the sensors for at least 70% of the time
- understands how to use it and is physically able to use the system
- has a structured education programme on diet and lifestyle, and counselling while using it.
- The person has fewer hypoglycaemic episodes after starting to use it.
NICE did not recommend the Vibe and G4 PLATINUM CGM system because more evidence is needed.
This page was last updated: 12 February 2016